Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs

Figures & data

Figure 1. Proportion of subjects hospitalized at least once during the 52-week study period.

#p = 0.024; chi-square test statistic to determine risk reduction.

Figure 2. Top three reasons for hospitalization during the 52-week study period.

Figure 3. Unique hospitalizations during the 52-week study period.

#p = 0.08, ANOVA model with treatment effects comparing FC versus AC average hospitalizations per subject.

ANOVA: Analysis of variance.

Figure 4. Estimated annual hospitalization costs.